XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

Three months ended
September 30, 

Nine months ended
September 30, 

    

2022

    

2021

2022

    

2021

Research and development

$

211

$

83

$

485

$

157

General and administrative

 

672

 

576

 

1,862

 

725

Stock-based compensation expense included in operating expenses

$

883

$

659

$

2,347

$

882

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2022:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term (in years)

(in thousands)

Outstanding at December 31, 2021

 

3,021,799

$

3.71

 

8.94

$

10,903

Granted

 

1,628,795

 

3.06

 

 

Exercised

(44,105)

0.43

Cancelled

(232,987)

4.24

Outstanding at September 30, 2022

 

4,373,502

 

3.47

 

8.86

$

477

Vested at September 30, 2022

 

1,189,491

 

1.95

 

8.66

$

316

Vested and expected to vest at September 30, 2022

 

4,373,502

$

3.47

 

8.86

$

477

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2021:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term ( in years)

(in thousands)

Outstanding at December 31, 2020

 

1,761,062

$

0.95

 

9.54

$

723

Granted

 

1,088,000

 

7.78

 

 

3,087

Outstanding at September 30, 2021

 

2,849,062

 

3.56

 

9.13

$

12,056

Vested at September 30, 2021

 

398,157

 

0.96

 

8.30

$

2,805

Vested and expected to vest at September 30, 2021

 

2,849,062

$

3.56

 

9.13

$

12,056

Schedule of assumptions used in estimation of fair value

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2022 and 2021 was $2.04 and $5.07 per share, respectively. The fair value of each stock option was estimated using a Black-Scholes option-pricing model with the following assumptions:

    

Three months ended September 30, 

 

Nine months ended September 30, 

 

2022

    

2021

 

2022

    

2021

 

Risk-free interest rate

 

2.71 - 3.47

%  

1.19

%

1.62 - 3.47

%  

0.95 - 1.19

%

Volatility

 

72

%  

76

%

72 - 80

%  

76 - 77

%

Dividend yield

 

0.00

%  

0.00

%

0.00

%  

0.00

%

Expected term (years)

 

6

 

6

6

 

6

Summary of restricted stock units activity

The following table summarizes activity related to RSUs:

    

    

Weighted- average

grant date

Number of shares

fair value

Unvested at December 31, 2021

 

200,996

$

16.00

Granted

 

 

Vested

(62,811)

$

16.00

Unvested at September 30, 2022

 

138,185

$

16.00